IndustryCompany release

BrightSpring raises 2026 guidance after Q3 revenue rises 26% to $4.2bn

🇺🇸 BrightSpring Health Services, Inc. (BTSG) · Fri 30 Oct 2026

The US home and community health and pharmacy group reported higher third-quarter earnings, lower leverage and an upgraded full-year outlook following the March sale of its Community Living business.

BrightSpring Health Services reported third-quarter 2026 results on 30 October, posting net revenue of $4,213 million. The headline growth figure of 26% comes from the company's own announcement title.

Net income from continuing operations was $101 million, and Adjusted EBITDA reached $228 million. Leverage fell to 1.79x. The results follow the company's divestiture of its Community Living business in March 2026.

BrightSpring raised its full-year 2026 guidance to $15.9 billion to $16.1 billion in revenue and $850 million to $860 million in Adjusted EBITDA. According to the company, the upgrade is driven by its pharmacy and provider services segments.

The source material available to VigiEye was limited to the headline and a summary, so segment-level detail, prior guidance figures and management commentary are not covered here.

What it means for your team

  • Pharmacy and provider services are the stated growth drivers, which is relevant for teams tracking specialty and home-based pharmacy channels in the US.
  • Market-access teams dealing with pharmacy and provider networks may see BrightSpring's expanded scale as a factor in contracting and distribution planning.
  • Segment-level disclosures were not available to VigiEye, so any operational or compliance implications should be checked against the full company filing.

Company's press release (SEC filing): BrightSpring Health Services, Inc. ↗

Article written by VigiEye from the official source (BrightSpring Health Services, Inc.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →